Furthermore, the relative magnitude of PPARγ coactivator 1α (PGC-1α), which plays a role in the pathogenesis of insulin resistance, was half of rosiglitazone and much higher than that of other coactivators. This evidence concerns the gene PPARGC1A and Insulin resistance.